Stock Photo - 24 April 2023, Baden-Württemberg, Biberach an der Riß: Ralf Schumacher, Head of Biotechnology at the pharmaceutical company Boehringer Ingelheim Pharma GmbH & Co. KG, explains a cell reactor to Winfried Kretschmann (Bündnis90/Die Grünen), Minister President of Baden-Württemberg, at the new development center. In the future, drugs based on cell technology will be developed here. Eight floors and a laboratory area of about five soccer fields: The pharmaceutical company Boehringer Ingelheim opened a new development center for biotechnology in Biberach on Monday. Here, scientists will develop new drugs and therapies with antibodies, proteins and viruses, for example. Photo: Stefan Puchner/dpa. - Biberach an der Riß/Baden-Württemberg/Germany

Stock Photo: 24 April 2023, Baden-Württemberg, Biberach an der Riß: Ralf Schumacher, Head of Biotechnology at the pharmaceutical company Boehringer Ingelheim Pharma GmbH &.

Searchable keywords

Choose multiple keywords